⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4294322 | 0.60 | — | — | |
| SCHEMBL1036617 | 0.56 | — | — | |
| SCHEMBL8273013 | 0.49 | — | — | |
| SCHEMBL4141702 | 0.49 | — | — | |
| SCHEMBL11688163 | 0.49 | CA1 (0.69) | — | |
| SCHEMBL1920577 | 0.48 | — | — | |
| SCHEMBL2723676 | 0.46 | — | — | |
| SCHEMBL391423 | 0.46 | — | — | |
| Hydrochloric Acid SCHEMBL29819829 | 0.44 | CA1 (0.88) | — | |
| SCHEMBL21356989 | 0.44 | CA1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104903320-B | Nitrogen-containing heterocycle compound or its salt | 富士胶片株式会社 | 2018-11-13 | — | — | CN | disclosed |
| CN-106019830-A | Resist composition and method for producing resist pattern | 住友化学株式会社 | 2016-10-12 | — | — | CN | disclosed |
| CN-104903320-A | Nitrogen-containing heterocylic compound or salt thereof | FUJIFILM CORP | 2015-09-09 | — | — | CN | disclosed |
| CN-102083427-B | Inhibitors of carbonic anhydrase IX | MOLECULAR INSIGHT PHARM INC | 2014-12-10 | — | — | CN | disclosed |
| CN-102186847-A | novel 2-amido thiadiazole derivatives | ALMIRALL SA | 2011-09-14 | — | — | CN | disclosed |
| CN-102083427-A | Inhibitors of carbonic anhydrase IX | MOLECULAR INSIGHT PHARM INC | 2011-06-01 | — | — | CN | disclosed |
| CN-101437513-A | Use of imidazo [2, 1-b ] -1, 3, 4-thiadiazole-2-sulfonamide compounds for the treatment of neuropathic pain | AEGERA THERAPEUTICS INC (CA) | 2009-05-20 | — | — | CN | disclosed |
| WO-2007062198-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | ADVANCED CELL TECHNOLOGY, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-1252178-A1 | ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | Bristol-Myers Squibb Pharma Company (US) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001040262-A1 | ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-06-07 | — | — | WO | disclosed |
| WO-1996017942-A9 | PRODUCTION OF PEPTIDES USING RECOMBINANT FUSION PROTEIN CONSTRUCTS | — | 1996-08-15 | — | — | WO | disclosed |